We further analyzed all available plasma-cfDNA and CTC-derived gDNA samples from the three breast cancer patients (Pt#11, Pt#12, Pt#13) that developed metastasis at different time points for ESR1 and PIK3CA mutations (Fig. 2). This evidence concerns the gene PIK3CA and breast carcinoma.